| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 03/10/2004 | CN1481367A Imidazole and benzimiddzole caspase inhibitors and uses thereof |
| 03/10/2004 | CN1481364A Urea and urethane derivatives as integrin inhibitors |
| 03/10/2004 | CN1481257A Compsn and its method |
| 03/10/2004 | CN1481244A Pharmaceutical formulation contg pyrazolo [4,3-D] pyrinidines, calcium antagonists, prostaglandins or prostaglandin derivatives |
| 03/10/2004 | CN1481243A Pharmaceutical formulation contg. thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2) |
| 03/10/2004 | CN1481242A Pharmaceutical formulation contg thienopyrimidines and antithrombotics, calcium-antagonists, prostaglandins or prostaglandin derivatives |
| 03/10/2004 | CN1481241A Therapeutic combination of amlodipine and benazepril/benazeprilat |
| 03/10/2004 | CN1480454A Antagon of endostadin receptor pyrazole carboxylic acids |
| 03/10/2004 | CN1480212A Application of neurotoxin therapy in treatment of urinary system and relative diseases |
| 03/10/2004 | CN1480207A Spore of gandoderma lucidum for treating disease of autoimmunity |
| 03/10/2004 | CN1480203A Preparation of Chinese herbal medicine to be taken after being mixed with boiling water for removal of urinary calculus |
| 03/10/2004 | CN1480195A Formula of Chinese herbal medicine of injection and bougie for treating kidney failure as well as its preparing method |
| 03/10/2004 | CN1480166A A kind of medication for expelling of toxin, normalizing gallbladder and protecting liver-preparation of cardoon |
| 03/10/2004 | CN1480165A Medical liquor for treating nephritis |
| 03/10/2004 | CN1480161A Preparation of Chinese herbal medicine for treating lithiasis as well as its preparing method |
| 03/10/2004 | CN1141295C Indoline derivatives as progesterohe antagonists |
| 03/10/2004 | CN1141134C Chinese patent medicine for acute and chronic renal failure and its preparation method |
| 03/09/2004 | US6703422 For therapy and prophylaxis of cardiovascular disease, dyslipidemia; dyslipoproteinemia; disorder of glucose metabolism; alzheimer's disease; syndrome x; peroxisome proliferator activated receptor-associated disorder |
| 03/09/2004 | US6703411 Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 03/09/2004 | US6703389 Optically pure reboxetine or its methanesulfonate salt inhibits reuptake of norepinephrine |
| 03/09/2004 | CA2260016C Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 03/05/2004 | CA2437690A1 Ganoderma lucidum spores for treatment of autoimmune diseases |
| 03/04/2004 | WO2004018436A2 Compounds derived from aryl carbamates, preparation thereof and uses of same |
| 03/04/2004 | WO2004018434A1 Pyrimidine compounds |
| 03/04/2004 | WO2004018431A2 Novel phenanthridines |
| 03/04/2004 | WO2004018430A1 COMPOUND HAVING TGFß INHIBITORY ACTIVITY AND MEDICINAL COMPOSITION CONTAINING THE SAME |
| 03/04/2004 | WO2004018425A1 N-4-piperidinyl compounds as ccr5 modulators |
| 03/04/2004 | WO2004018412A1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 03/04/2004 | WO2004017997A1 Remedy or preventive for kidney disease and method of diagnosing kidney disease |
| 03/04/2004 | WO2004017966A1 Five-membered heterocyclic compounds in the treatment of chronic and acute pain |
| 03/04/2004 | WO2004017965A1 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain |
| 03/04/2004 | WO2004017960A1 Treatment of lower urinary tract symptoms associated with overactive bladder in men and women |
| 03/04/2004 | WO2004017954A1 Agent for reducing side effects of diclofenac |
| 03/04/2004 | WO2004017906A2 Modulation of matrix metalloproteinase (mmp) activity with aldosterone blocker(s) |
| 03/04/2004 | WO2003106456A3 Azabicyclo-octane and nonane derivatives with ddp-iv inhibiting activity |
| 03/04/2004 | WO2003103577A3 Novel recombinant anticoagulant proteins |
| 03/04/2004 | WO2003079993A3 hGH (HUMAN GROWTH HORMONE) FORMULATIONS FOR PULMONARY ADMINISTRATION |
| 03/04/2004 | WO2003073107A3 Neuropeptide receptor and uses thereof |
| 03/04/2004 | WO2003065871A3 Methods and compositions for treating hematological disorders |
| 03/04/2004 | WO2003050067A3 Vitamin d analogues |
| 03/04/2004 | WO2003032916A3 Organosulfur inhibitors of tyrosine phosphatases |
| 03/04/2004 | WO2002096867A3 Inhibitors of protein kinase for the treatment of disease |
| 03/04/2004 | WO2002094178A3 Treatment of renal fibrosis |
| 03/04/2004 | WO2002085459A3 Antiangiogenic combination therapy for the treatment of cancer |
| 03/04/2004 | US20040044241 Novel succinate salt of O-desmethyl-venlafaxine |
| 03/04/2004 | US20040044213 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 03/04/2004 | US20040044212 (Dihydro) Isoquinoline derivatives as phosphodiesterase inhibitors |
| 03/04/2004 | US20040044194 Aggrecanase molecules |
| 03/04/2004 | US20040044082 Adrenergic receptor antagonist |
| 03/04/2004 | US20040044061 Analgesics; side effect reduction |
| 03/04/2004 | US20040044057 5- substituted tetralones as inhibitors of ras farnesyl trransferase |
| 03/04/2004 | US20040044056 Benzimidazole derivatives |
| 03/04/2004 | US20040044051 Cannabinoid receptor agonists |
| 03/04/2004 | US20040044050 Antiinflammatory agents; cardiovascular disorders; vision disorders; skin disorders; central nervous system disorders; antiarthritic agents |
| 03/04/2004 | US20040044044 Thiazolyl urea compounds and methods of uses |
| 03/04/2004 | US20040044036 Piperidine derivatives and drugs containing these derivatives as active ingredient |
| 03/04/2004 | US20040044018 Methods and pharmaceutical compositions for treatment of central and peripheral nervous system disorders and compounds useful therefor |
| 03/04/2004 | US20040044003 Therapeutic agents useful for treating pain |
| 03/04/2004 | US20040044002 Kinase inhibitors; antiproliferative agents; antiinflammatory agents; autoimmune diseases; skin disorders; anticancer agents; antiproliferative agents |
| 03/04/2004 | US20040043998 Preventive or therapeutic medicines for diabetes containing fused-heterocyclic compounds or their salts |
| 03/04/2004 | US20040043968 Use of 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treatment of urinary incontinence |
| 03/04/2004 | US20040043929 Novel proteins and nucleic acids encoding same |
| 03/04/2004 | US20040043926 Comprises polypeptides for diagnosing, treating and preventing cardiomyopathy, atherosclerosis and cancer |
| 03/04/2004 | CA2501719A1 Remedy or preventive for kidney disease and method of diagnosing kidney disease |
| 03/04/2004 | CA2495597A1 Novel phenanthridines |
| 03/04/2004 | CA2495376A1 Modulation of matrix metalloproteinase (mmp) activity with aldosterone blocker(s) |
| 03/04/2004 | CA2494210A1 Treatment of lower urinary tract symptoms associated with overactive bladder in men and women |
| 03/03/2004 | EP1394551A2 Integrin as a predictor of endometriosis |
| 03/03/2004 | EP1394161A1 L−ASCORBIC ACID−2−O−MALEIC ACID−A−TOCOPHEROL DIESTER 1−PROPANOL ADDUCT AND PROCESS FOR PRODUCING THE SAME |
| 03/03/2004 | EP1394152A1 2-iminoimidazole derivatives (1) |
| 03/03/2004 | EP1393731A1 Novel use of arylethenesulfonamide derivative |
| 03/03/2004 | EP1392852A2 Nucleic acid-associated proteins |
| 03/03/2004 | EP1392844A2 Use of hmg fragments as anti-inflammatory agents |
| 03/03/2004 | EP1392823A2 Desaturase genes and uses thereof |
| 03/03/2004 | EP1392688A1 Pyrazino[1',2':1,6]pyrido[3,4-b]indole1,4-dione derivatives |
| 03/03/2004 | EP1392680A2 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3 |
| 03/03/2004 | EP1392677A2 Chiral broad-spectrum antibacterial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation and compositions |
| 03/03/2004 | EP1392670A1 Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives |
| 03/03/2004 | EP1392662A1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments |
| 03/03/2004 | EP1392661A1 Diarylurea derivatives useful as anti-inflammatory agents |
| 03/03/2004 | EP1392655A2 Potassium channel openers |
| 03/03/2004 | EP1392651A1 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists |
| 03/03/2004 | EP1392648A1 Hydroxamic acids and acyl hydroxamines as naaladase inhibitors |
| 03/03/2004 | EP1392643A2 Trisubstituted-n- (1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors |
| 03/03/2004 | EP1392641A1 Substituted cyclohexane-1,4-diamine derivatives |
| 03/03/2004 | EP1392399A1 Use and compositions of antiprogestins for treatment of prostate diseases |
| 03/03/2004 | EP1392360A2 Modified antibodies to prostate-specific membrane antigen and uses thereof |
| 03/03/2004 | EP1392351A2 Chemokines as adjuvants of immune response |
| 03/03/2004 | EP1392337A1 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating |
| 03/03/2004 | EP1392327A2 Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases |
| 03/03/2004 | EP1392326A1 Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| 03/03/2004 | EP1392325A1 Method of administration of bisphosphonates by inhalation in the treatment or prevention of bone resorption and osteoporosis |
| 03/03/2004 | EP1392317A2 Substituted 1-benzazepines and derivatives thereof |
| 03/03/2004 | EP1392307A1 Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene |
| 03/03/2004 | EP1392304A1 Use of benzothiophenes to treat and prevent prostate cancer |
| 03/03/2004 | EP1392300A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors |
| 03/03/2004 | EP1392297A1 Pharmaceutical composition comprising a tricyclic compound for the prevention or treatment of skin diseases |
| 03/03/2004 | EP1392289A2 Caspase inhibitors and uses thereof |
| 03/03/2004 | EP1392286A2 Antineoplastic combinations |
| 03/03/2004 | EP1392285A1 Medicament containing an effector of the glutathione metabolism together with alpha-lipoic acid for use in kidney replacement therapy |